Concepedia

Karen M. Miner

KM

9

Publications

492

Citations

9

H-Index

1974

Active since

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

The University of Texas System

Karen M. Miner is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in medicine, pathology, and tumor biology.

Top concepts

Publications per year

1974–1988

9

Publications

9

Clonal drift of cell surface, melanogenic, and experimental metastatic properties of in vivo-selected, brain meninges-colonizing murine B16 melanoma.

Karen M. Miner, Takanori Kawaguchi, Grant W. Uba et al. · PubMed · 1982 · 125 citations

, , +13

Differences in the sensitivities of murine metastatic lymphoma/lymphosarcoma variants to macrophage-mediated cytolysis and/or cytostasis.

Karen M. Miner, Garth L. Nicolson · PubMed · 1983 · 66 citations

, , +14

Characterization of murine monoclonal antibodies to Escherichia coli J5

Karen M. Miner, C L Manyak, Emily L. Williams et al. · Infection and Immunity · 1986 · 63 citations · Full text

, , +14

Sodium-Stimulated Glutamate Transport in Osmotically Shocked Cells and Membrane Vesicles of <i>Escherichia coli</i>

Karen M. Miner, Leonard Frank · Journal of Bacteriology · 1974 · 53 citations · Full text

, , +21

Subfractionation of malignant variants of metastatic murine lymphosarcoma cells by countercurrent distribution in two-polymer aqueous phases

Karen M. Miner, Harry Walter, Garth L. Nicolson · Biochemistry · 1981 · 46 citations

, , +19

Rows per page

1–5 of 9